Chitosan Coated PLA Nanoparticles for Ophthalmic Delivery: Characterization, In-Vitro and In-Vivo Study in Rabbit Eye

被引:56
作者
Nagarwal, Ramesh C. [1 ]
Singh, P. N. [1 ]
Kant, S. [3 ]
Maiti, P. [2 ]
Pandit, J. K. [1 ]
机构
[1] Banaras Hindu Univ, Dept Pharmaceut, IT, Varanasi 221005, Uttar Pradesh, India
[2] Banaras Hindu Univ, Sch Mat Sci & Technol, IT, Varanasi 221005, Uttar Pradesh, India
[3] Banaras Hindu Univ, Dept Ophthalmol, IMS, Varanasi 221005, Uttar Pradesh, India
关键词
Poly; (D; L-lactic acid); Nanoparticles; Ophthalmic Delivery; 5-Fluorouracil; Aqueous Humor; Cornea; Chitosan; Polyvinyl Alcohol; Poloxomer; SQUAMOUS-CELL CARCINOMA; 5-FLUOROURACIL; MICROSPHERES; SYSTEM; NANOSPHERES; SURFACE;
D O I
10.1166/jbn.2010.1168
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The objective of the present study is to develop a poly (D, L-lactic acid) (PLA) nano-carrier for topical ocular applications. PLA nanoparticles (PLA-NPs) with 5-fluorouracil were prepared using varying concentration and molecular weight of PLA to regulate the particle size. The dimension and shape of nanoparticles were verified by using dynamic light scattering (DLS), atomic force microscope (AFM) and scanning electron microscope (SEM). Ex-vivo permeation study was conducted by goat and rabbit excised cornea. In-vivo experiment was conducted in rabbit eye and 5-FU concentration was measured in aqueous and vitreous humor by HPLC. In-vitro experiments indicated a diffusion controlled release of 5-FU. No significant interaction was observed in between mucin and PLA NPs that measured in terms of viscosity change. Ex-vivo permeation was significantly higher with rabbit cornea as compared to goat cornea. PLA and CH-PLA DNPs showed increased level of 5-FU as comparison to 5-FU solution. In-vivo study showed significantly higher concentration in case of uncoated and CH coated PLA nanoparticles in rabbit eye as compared to free 5-FU solution. PLA nanoparticle was found non-irritant in nature by modified Draize test.
引用
收藏
页码:648 / 657
页数:10
相关论文
共 25 条
[1]  
Al-Barrag A, 2010, CLIN OPHTHALMOL, V4, P801
[2]   Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers [J].
Calvo, P ;
VilaJato, JL ;
Alonso, MJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 153 (01) :41-50
[3]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[4]   Ionically Crosslinked Chitosan Nanoparticles as Gene Delivery Systems: Effect of PEGylation Degree on In Vitro and In Vivo Gene Transfer [J].
Csaba, Noemi ;
Koping-Hoggard, Magnus ;
Fernandez-Megia, Eduardo ;
Novoa-Carballal, Ramon ;
Riguera, Ricardo ;
Jose Alonso, Maria .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2009, 5 (02) :162-171
[5]   Chitosan nanoparticles:: a new vehicle for the improvement of the delivery of drugs to the ocular surface.: Application to cyclosporin A [J].
De Campos, AM ;
Sánchez, A ;
Alonso, MJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 224 (1-2) :159-168
[6]  
Felt O., 1999, INT J PHARMACEUT, V53, P41
[7]   Development of novel 5-FU-loaded poly(methylidene malonate 2.1.2)-based microspheres for the treatment of brain cancers [J].
Fournier, E ;
Passirani, C ;
Colin, N ;
Breton, P ;
Sagodira, S ;
Benoit, JP .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (02) :189-197
[8]   Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability [J].
Giannavola, C ;
Bucolo, C ;
Maltese, A ;
Paolino, D ;
Vandelli, MA ;
Puglisi, G ;
Lee, VHL ;
Fresta, M .
PHARMACEUTICAL RESEARCH, 2003, 20 (04) :584-590
[9]  
GREAVES JK, 1996, ADV DRUG DEL REV, V11, P349
[10]   PLGA nanoparticles for the oral delivery of 5-fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies [J].
Li, XueMing ;
Xu, YuanLong ;
Chen, GuoGuang ;
Wei, Ping ;
Ping, QiNeng .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2008, 34 (01) :107-115